|
Check with your doctor if you have undergone treatment for AAA and
believe that you might have received a potentially defective Ancure
unit. If so, then follow your doctor's medical advice as to what to do
next.
This is what the FDA has told doctors about Ancure.
Stay Informed.
Endovascular repair of AAA is a new and evolving technology, and both
Ancure® and AneuRx® have undergone changes in design and labeling
during the premarket and postmarket phases. Anticipate that there will
be changes and improvements as more clinical experience accumulates
with this class of devices. We recommend that you carefully follow the
device manufacturer's most recent warnings, precautions, and
instructions regarding patient selection and device use.
Make sure that all
implanted patients are carefully followed, and undergo periodic
follow-up imaging. Patients who are unlikely to adhere to the
manufacturer's graft follow-up recommendations may be poor candidates
for endovascular repair, even if they are otherwise suitable. Problems
that are identified through follow-up imaging may be amenable to
further endovascular repair (e.g. additional stent placement), or
might require conversion to open aneurysm resection.
Report problems you
encounter with the use of these devices, as well as adverse
events, to the manufacturer and to the FDA. We will only be able to
assess the risk/benefit of these devices, as well as their ultimate
clinical usefulness, if we have open communication with practitioners
who use them.
If you have been damaged
by an Ancure unit, or if you feel that Ancure has put you at risk, then
contact a qualified attorney to discuss possible legal action. Ancure
has already admitted fault in this case.
Do I have a case? |
 |
